Stay updated on Belumosudil for Idiopathic Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Belumosudil for Idiopathic Pulmonary Fibrosis Clinical Trial page.

Latest updates to the Belumosudil for Idiopathic Pulmonary Fibrosis Clinical Trial page
- Check5 days agoChange DetectedA site-wide NIH notice about terminology changes during its website transition was added, and the displayed site revision changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe ClinicalTrials.gov error page now displays site revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check33 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study details, indicating that access to the record is restricted or unavailable.SummaryDifference23%

- Check40 days agoChange DetectedRevision: v3.7.0 has been applied, replacing the previous v3.6.6. This update indicates a new page build/version but does not alter the displayed study data.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6. This indicates a page maintenance update to the study record.SummaryDifference0.0%

- Check75 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5, indicating a new page build.SummaryDifference0.0%

Stay in the know with updates to Belumosudil for Idiopathic Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belumosudil for Idiopathic Pulmonary Fibrosis Clinical Trial page.